Royal Bank Of Canada Celldex Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 3,030 shares of CLDX stock, worth $55,449. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,030

Previous 7,753 60.92%

Holding current value

$55,449

Previous $263,000 71.1%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$23.31 - $32.4 $110,093 - $153,025	-4,723 Reduced 60.92%	3,030 $76,000
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $36,131 - $50,219	1,127 Added 17.01%	7,753 $263,000
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $155,773 - $202,372	4,755 Added 254.14%	6,626 $245,000
Q1 2024 Nov 05, 2024	SELL	$35.22 - $51.88 $167,471 - $246,689	-4,755 Reduced 71.76%	1,871 $78,000
Q1 2024 May 15, 2024	SELL	$35.22 - $51.88 $461,875 - $680,354	-13,114 Reduced 87.51%	1,871 $78,000
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $163,176 - $293,371	7,217 Added 92.91%	14,985 $594,000
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $69,962 - $102,977	2,749 Added 54.77%	7,768 $213,000
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $72,908 - $92,139	2,407 Added 92.15%	5,019 $170,000
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $96,305 - $131,333	-2,769 Reduced 51.46%	2,612 $93,000
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $133,010 - $217,279	4,788 Added 807.42%	5,381 $239,000
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $6,605 - $10,932	291 Added 96.36%	593 $17,000
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $51,803 - $94,332	-2,527 Reduced 89.32%	302 $8,000
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $185,602 - $264,033	-6,715 Reduced 70.36%	2,829 $96,000
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $155,457 - $245,168	4,357 Added 84.0%	9,544 $368,000
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $72,461 - $140,142	2,503 Added 93.26%	5,187 $280,000
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $55,585 - $94,933	2,684 New	2,684 $90,000

Others Institutions Holding CLDX

# of Institutions

199

Shares Held

60.8M

Call Options Held

960K

Put Options Held

675K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $856M
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Celldex Therapeutics, Inc. Transaction History